Laddar...
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
Immune checkpoint inhibitors are becoming standard treatments in several cancer types, profoundly changing the prognosis of a fraction of patients. Currently, many efforts are being made to predict responders and to understand how to overcome resistance in non-responders. Given the crucial role of m...
Sparad:
| I publikationen: | Front Immunol |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Frontiers Media S.A.
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7393010/ https://ncbi.nlm.nih.gov/pubmed/32793228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01590 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|